We bring you the latest news from the healthcare about the health care in the United Kingdom.

vrijdag 20 april 2018

Oncogene - Table of Contents alert Volume 37 Issue 16

If you are unable to see the message below, click here to view.
Oncogene

TABLE OF CONTENTS

Volume 37, Issue 16

In this issue
Review Article
Article
Also new
AOP

Review Article

MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells

Hasan Rajabi, Masayuki Hiraki & Donald Kufe

Oncogene 2018 37 :2079 - 2088; January 30, 2018; 10.1038/s41388-017-0096-9

Abstract | Full Text

Article

Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype

Md Zahid Akhter, Surender K Sharawat, Vikash Kumar, Veena Kochat, Zaffar Equbal et al.

Oncogene 2018 37 :2089 - 2103; January 30, 2018; 10.1038/s41388-017-0106-y

Abstract | Full Text

c-Src activity is differentially required by cancer cell motility modes

Jeremy S. Logue, Alexander X. Cartagena-Rivera & Richard S. Chadwick

Oncogene 2018 37 :2104 - 2121; January 30, 2018; 10.1038/s41388-017-0071-5

Abstract | Full Text

The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim

Lazaro E. Aira, Elodie Villa, Pascal Colosetti, Parvati Gamas, Laurie Signetti et al.

Oncogene 2018 37 :2122 - 2136; February 02, 2018; 10.1038/s41388-017-0112-0

Abstract | Full Text

Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379

K. P. O'Brien, S. Khan, K. E. Gilligan, H. Zafar, P. Lalor et al.

Oncogene 2018 37 :2137 - 2149; January 25, 2018; 10.1038/s41388-017-0116-9

Abstract | Full Text

A functional interplay between ?133p53 and ?Np63 in promoting glycolytic metabolism to fuel cancer cell proliferation

Lu Gong, Xiao Pan, Chuan-Bian Lim, Anna de Polo, John B. Little et al.

Oncogene 2018 37 :2150 - 2164; January 26, 2018; 10.1038/s41388-017-0117-8

Abstract | Full Text

TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer

Ken-ichi Takayama, Takashi Suzuki, Tomoaki Tanaka, Tetsuya Fujimura, Satoru Takahashi et al.

Oncogene 2018 37 :2165 - 2180; January 30, 2018; 10.1038/s41388-017-0095-x

Abstract | Full Text

Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99

Haydar Çelik, Marika Sciandra, Bess Flashner, Elif Gelmez, Neslihan Kayraklioglu et al.

Oncogene 2018 37 :2181 - 2196; January 31, 2018; 10.1038/s41388-017-0080-4

Abstract | Full Text

Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-ß-dependent and -independent mechanisms

Jun Nishida, Kohei Miyazono & Shogo Ehata

Oncogene 2018 37 :2197 - 2212; February 02, 2018; 10.1038/s41388-017-0084-0

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature